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The midbrain–hindbrain boundary (MHB) acts as a local organizer in the development of the CNS in vertebrates. Previously, we
identified an MHB-specific bHLH-WRPW transcriptional repressor gene, Xenopus Hes-related 1 (XHR1), which is initially expressed in the
presumptive MHB (pre-MHB) region at the early gastrula stage. To better understand the gene cascades involved in MHB formation, we
investigated the genes downstream from XHR1 by differential screening using a Xenopus cDNA macroarray and a dexamethasone (DEX)-
inducible, dominant-negative transcriptional activator construct of XHR1 (XHR1-VP16-GR). Among the newly identified candidate target
genes of XHR1 were Enhancer of split-related genes (ESR1, ESR3/7, and ESR9) and Xenopus laevis cleavage 2 (XLCL2). XHR1-VP16-GR
induced the expression of the ESR genes and XLCL2 as well as Xdelta1, Xngnr1, and XHR1 itself in the presence of DEX even after
pretreatment with the protein synthesis inhibitor, cycloheximide. This suggests that these genes are direct targets of XHR1. XHR1-
knockdown experiments with antisense morpholino oligos and ectopic expression of wild-type XHR1 revealed that XHR1 is necessary and
sufficient to repress ESR genes in the pre-MHB region. Misexpression of the ESR genes in the pre-MHB region repressed the MHB marker
gene, Pax2, suggesting that the repression of the ESR genes by XHR1 is at least partly required for the early development of the pre-MHB.
Our data also show that XHR1 is not activated by Notch signaling, differing from ESR genes. Taken together, we propose a model in which
XHR1 defines the pre-MHB region as a prepattern gene by repressing those possible direct target genes.
D 2005 Elsevier Inc. All rights reserved.Keywords: Xenopus; Midbrain–hindbrain boundary; Prepattern gene; bHLH-WRPW; XHR1; ESR1; ESR3/7; ESR9; XLCL2; Cl2; Lbh; Xdelta1; Xngnr1;
NotchIntroduction
The development of multicellular organisms requires
many steps of spatially and temporally coordinated induc-
tion, patterning, regionalization, and cell fate decisions. In
the development of the vertebrate nervous system, the
Spemann–Mangold organizer in amphibians or its equiv-0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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California at Los Angeles, Los Angeles, CA 90095, USA.alent tissue in other vertebrates is responsible for the neural
induction and initial patterning of the resulting neuro-
ectoderm (De Robertis et al., 2000; Harland and Gerhart,
1997). At later stages, the neural plate or neural tube
undergoes further patterning processes, which lead to the
formation of morphologically and functionally distinct
regions of the central nervous system (CNS) (Bally-Cuif
and Hammerschmidt, 2003; Lumsden and Krumlauf, 1996).
In the course of CNS development, various sets of neuronal
and glial cells arise from undifferentiated progenitor cells at
defined times and in defined regions, and eventually create
the intricate neuronal network of this nervous system (Qian
et al., 2000).283 (2005) 253 – 267
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vertebrate CNS is also attributed to the activity of local
organizers that are situated in the neural plate or neural
tube, and induce subsets of brain structures. The mid-
brain–hindbrain boundary (MHB) is one of the best
studied local organizers, inducing the tectum from the
midbrain and the cerebellum from the anterior part of the
hindbrain, as has been shown in the chick and mouse.
The molecules responsible for the induction properties of
the MHB have been identified as Fgf8 and Wnt1, and
their expression depends on the homeobox genes, Pax2/5/
8 and En1/2. These secreted molecules and transcription
factors are also necessary for the formation and main-
tenance of the MHB region, as has been shown by mutant
analyses in mice and zebrafish (Martinez, 2001; Rhinn
and Brand, 2001; Wurst and Bally-Cuif, 2001). Other
MHB genes that are thought to be necessary for the
establishment of the MHB are the Xenopus gene, XHR1,
encoding the proline-basic helix– loop–helix (bHLH)
transcriptional repressor (Shinga et al., 2001), and the
zebrafish genes including the POU domain transcription
factor gene Spg/POU2, the Xenopus ortholog of which is
Oct25 (Belting et al., 2001), the zinc-finger protein gene
Bts1 (Tallafuss et al., 2001), and the homeobox genes
Iro1 and Iro7 (Glavic et al., 2002; Itoh et al., 2002).
Thus, multiple genes are involved in specifying the MHB
as a local organizer for neural patterning.
Although the mechanisms underlying the induction
properties and establishment of the MHB have been
extensively studied, the initial step in MHB formation is
not yet thoroughly understood. The MHB has been thought
to be defined by two mutually repressing homeodomain
transcription factors, Otx2 and Gbx2, which are expressed
in the region anterior and posterior to the presumptive
MHB (pre-MHB), respectively, and which control the
expression of MHB genes such as Pax2, En2, and Fgf8
(Joyner et al., 2000; Millet et al., 1999; Simeone, 2000). In
our previous expression pattern screening for early neural
genes, we identified a novel MHB gene, XHR1, in
Xenopus. We found that XHR1 expression begins in the
pre-MHB region at the early gastrula stage before the
expression of the previously identified MHB marker genes,
Pax2, En2, and Fgf8. XHR1 expression only partially
overlaps that of Otx2 and Gbx2 at this stage, implying that
interactions between Otx2 and Gbx2 are not necessary for
the initiation of XHR1 expression (Shinga et al., 2001).
This observation is supported by a genetic study with mice
in which the Otx2 and Gbx2 genes were both knocked out,
demonstrating that these two genes are not required for the
initiation of MHB gene expression, but instead are involved
in refining the positioning of the pre-MHB region (Li and
Joyner, 2001). Thus, the initial step in pre-MHB formation
and the gene cascade from the pre-MHB to the MHB have
not yet been clarified.
It has been proposed that the pre-MHB region carries
unique characteristics, in which neurogenesis is activelyrepressed. The zebrafish MHB gene her5, which is a
homolog of XHR1, is required to repress neurogenin 1 and
the Cdk inhibitor p27xic1 in order to maintain the pre-
MHB neuron-free (Geling et al., 2003). In the mouse,
when the hairy/Enhancer of split [E(spl)] genes, HES1
and HES3, were knocked out, premature neuronal differ-
entiation was observed in the MHB region. This in turn
led to the premature termination in this region of the
expression of Wnt1, Fgf8, Pax2/5/8, and En1/2, which
subsequently caused the loss of the midbrain and anterior
hindbrain structures (Hirata et al., 2001). These data
suggest that the temporal repression of neuronal differ-
entiation in the MHB region is critical for the inductive
activity of MHB.
It is therefore important to investigate the mechanism of
MHB formation as one of the earliest events in neural
patterning, and also to examine the relationship between
cell fate decisions and patterning in the CNS. To address
these subjects, we investigated the target genes of the
earliest MHB-specific transcriptional repressor, XHR1,
during the specification of the pre-MHB region. We have
previously shown that a dominant-negative activator form
of XHR1, XHR1-VP16, disrupts the morphological fea-
tures of the MHB and reduces the expression of the MHB
marker genes Pax2 and En2. Conversely, misexpression of
XHR1 expands En2 expression, suggesting that XHR1
plays an important role in the specification and positioning
of the MHB. In this study, we undertook a large-scale
screening for XHR1 target genes, using a Xenopus cDNA
macroarray with hormone-inducible XHR1-VP16, desig-
nated XHR1-VP16-GR. Our functional analyses using
mRNA and antisense-morpholino oligo injections suggest
that XHR1 acts as a prepattern factor in pre-MHB
development by repressing various genes which include
E(spl)-related genes induced by Notch signaling (Davis and
Turner, 2001), a Notch ligand, Xdelta1, and a possible
coactivator gene, XLCL2/Lbh (Briegel and Joyner, 2001;
Paris and Philippe, 1990).Materials and methods
Manipulations of Xenopus embryos
Artificial fertilization and rearing of pigmented and
albino embryos were performed as described previously
(Shinga et al., 2001). Embryos were staged according to
Nieuwkoop and Faber (Nieuwkoop and Faber, 1967).
Embryos injected with mRNA for enhanced green fluores-
cent protein (eGFP) as a tracer (see below) were dissected at
the late gastrula to early neurula stage with fine forceps
under a fluorescent dissection microscope (Leica) to isolate
the dorsoanterior tissue that contains the pre-MHB region
(see Fig. 1C). The dissected pieces were treated with
collagenase (0.75 mg/mL) in 1  MBS (modified Barth’s
solution) for 3 min at room temperature to separate the
Fig. 1. Preparations for macroarray screening. (A) Pax2 is downregulated by XHR1-VP16-GR only in the presence of DEX (indicated by arrow). mRNAs for
XHR1-VP16-GR (12.5 pg) and nh-gal were coinjected into the dorsoanimal region of the left blastomere at the four-cell stage. Half the injected embryos were
treated with DEX at the early gastrula stage (stage 10.5–11) (right) and the other half were untreated (left). Following nh-gal staining (red), WISH was
performed with a Pax2 probe at the early neurula stage (stage 13–14; purple). The images are dorsal views with the anterior to the top (the orientation of the
following figures is the same as shown here unless otherwise stated). (B) Pax2 expression levels and gastrulation-arrest rates upon DEX treatment at different
stages. Embryos were coinjected as described in panel (A) with mRNAs for XHR1-VP16-GR or h-globin (100 pg) and nh-gal, treated with DEX from the
indicated stages to stage 13–14, and subjected to WISH for Pax2 expression. Colored bars indicate Pax2 expression levels on the injected side. Percentages of
embryos with gastrulation arrest are shown on the right side of the graph. N, number of embryos. Each datum is from two or more individual experiments. (C)
A schematic representation of the dissection procedure used to isolate the anterior neuroectoderm containing the pre-MHB region. Embryos were injected with
mRNA at the four-cell stage, cut into halves in the middle of the body length at the late gastrula to early neurula stage (stage 12.5–13). The anterior
neuroectoderm (ANE) together with the underlying anterior endomesoderm (AEM) was dissected and separated by collagenase digestion. (D, E) Dissected
fragments containing the pre-MHB region as ascertained by XHR1 expression visualized by WISH (D), or by RT-PCR of extracted total RNA for XHR1
expression (E). Histone H4 was used as the loading control.
H. Takada et al. / Developmental Biology 283 (2005) 253–267 255neuroectoderm containing the pre-MHB region from the
underlying endomesoderm.
Plasmid construction and in vitro mRNA synthesis
The human glucocorticoid hormone receptor ligand-
binding domain (GR) (nucleotides 1666–2463; accession
no. NM000176) and the VP16 activation domain (nucleo-
tides 418–651; accession no. U89963) were PCR-amplified
with Pfu DNA polymerase and the following sets of primers
carrying the indicated restriction enzyme sites (underlined):
5V-GCTCTAGAACGCGTTCTGAAAATCCTGGTAA-
3V (GR-F1, XbaI); 5V-GGACTAGTGCTAGCTCACT-TTTGATGAAACAGAA-3V (GR-R1, SpeI –NheI); 5V-
CCGCTCGAGGCCCCCCCGACCGATGT-3V (VP16-F2,
XhoI); and 5V-GCTCTAGACCCACCGTACTCGTCAA-3V
(VP16-R2, XbaI). PCR products were cleaved with the
appropriate restriction enzymes and cloned sequentially into
the XbaI and XhoI sites of the pCS2+ vector to construct
pCS2 + VP16-GR. A BamHI–SphI fragment of pCS2 +
XHR1-VP16 was cloned into the pCS2 + VP16-GR vector
cleaved with the same set of restriction enzymes to construct
pCS2 + XHR1-VP16-GR (note that SphI is an internal site
of VP16). The coding sequences of ESR1 and XLCL2
cDNA were Pfu-PCR-amplified from the National Institute
for Basic Biology (NIBB) expressed sequence tag (EST)
H. Takada et al. / Developmental Biology 283 (2005) 253–267256clones, and cloned into the NcoI and EcoRI sites of the
pCS2+AdN vector (Mochizuki et al., 2000), and EcoRI and
XhoI sites of the pCS2+ vector to construct pCS2+ESR1
and pCS2+XLCL2, respectively. Template preparation and
in vitro synthesis and quantification of mRNAs were
performed as described previously (Hiratani et al., 2001).
Other plasmids used for mRNA synthesis were pSP64-Xhm
(h-globin) (Krieg and Melton, 1984), pCS2+eGFP,
pCS2+nh-gal (nuclear h-galactosidase), pCS2+Xnotch-
ICD (Chitnis et al., 1995), and pCS2+Su(H)1DBM (Wettstein
et al., 1997).
Injection of mRNA and antisense morpholino oligos
Embryoswere injectedwithmRNAs (3–10 nl/blastomere)
and cultured until the embryos reached the appropriate stage.
nh-gal mRNA (30 pg/blastomere) was coinjected as a lineage
tracer and the enzymatic activity of nh-galwas visualizedwith
Red-Gal (Research Organics) as substrate. Dexamethasone
(DEX; 20 mM in ethanol) and cycloheximide (CHX; 10 mg/
mL in water) were added to the incubation medium to final
concentrations of 10 AM and 10 Ag/mL, respectively.
Antisensemorpholino oligoswhichwere designed to comple-
ment 25-nucleotide sequences upstream from the start codon
of XHR1 pseudoalleles, XHR1A/B and A’ (XHR1-MO2, 5V-
GGTAAGATGATGATGATGATGAAGA-3V; and XHR1-
MO3, 5V-GGTAAGATGATGATGACGATGATGA-3V,
respectively), a five-base-mismatched control oligo for both
XHR1-MO2 and XHR1-MO3 (XHR1-5mmMO, 5V-
GGTAACATAATGATGAAGAAGACGA-3V; mismatched
nucleotides are underlined), and a nonspecific control oligo
were purchased from Gene Tools. XHR1-MO2 and XHR1-
MO3 were used as a mixture of equal amounts, hereafter
called XHR1-MOs.
cDNA macroarray analysis
Five cDNA macroarray membranes were prepared with a
total of 48,000 clones from Xenopus laevis normalized
cDNA libraries constructed from stage 10.5 (5760 clones),
stage 15 (19,200 clones), and stage 25 (23,040 clones)
embryos. ESTs of these clones were deposited in DDBJ/
GenBank. 32P-Labeled cDNA probes were prepared as
follows. Total RNA was extracted from dissected pre-MHB
regions using a guanidinium isothiocyanate-acid phenol
method (Chomczynski and Sacchi, 1987) with some
modifications. Total RNA (5.6–15.7 Ag) was reverse-
transcribed with oligo dT primer and four dNTPs containing
[32P]dCTP for 30 min at 37-C in a 29-Al reaction mixture,
then incubated for another 2 h after the addition of cold 0.5
mM dCTP. cDNA probes were purified with Probe Quant
G50 (Pharmacia), denatured, and hybridized to cDNA
macroarray membranes in hybridization solution [5  saline
sodium citrate (SSC), 5  Denhardt’s, 0.1% sodium dodecyl
sulfate (SDS), 0.1 mg/mL salmon sperm DNA] at 65-C
overnight. Filters were washed four times: with 2  SSC,0.1% SDS at 55-C for 5 and 55 min, and with 0.2  SSC,
0.1% SDS at 65-C for 70 and 80 min. The membranes were
exposed to an imaging plate which was analyzed with BAS
5000 (Fuji). The relative intensity of each clone was
quantified and normalized against the global background
signal (ArrayGauge).
Whole-mount in situ hybridization
Whole-mount in situ hybridization (WISH) was per-
formed with pigmented or albino embryos according to the
method of Harland (Harland, 1991), using an automated
AIH101 or AIH201 system (Aloka). Digoxigenin (DIG)- or
fluorescein isothiocyanate (FITC)-labeled antisense RNA
probes were synthesized from either linearized plasmid
DNAs or PCR products, using T7 RNA polymerase.
Pigmented embryos were bleached with 10% H2O2 in
MeOH after a chromogenic reaction with BM Purple
(Roche) and extensive washing with maleate buffer. Stained
embryos were cleared with benzyl benzoate/benzyl alcohol
(BB:BA = 2:1) as indicated. For double in situ hybrid-
ization, fixed albino embryos were hybridized with a
mixture of DIG- and FITC-labeled probes. For the first
round of staining, hybridized embryos were incubated with
anti-FITC antibodies conjugated with alkaline phosphatase
for staining with 5-bromo-4-chloro-3-indolyl phosphate
(BCIP, Roche; turquoise color). Before the second round
of staining, alkaline phosphatase was inactivated by
sequential treatments of BCIP-stained embryos with 25%,
50%, 75%, 100%, 75%, 50%, and 25% methanol in maleate
buffer for 5 min each, except for the 100% treatment which
was for 1 h. The embryos were then incubated with anti-
DIG antibodies conjugated with alkaline phosphatase and
stained with BM Purple (purple color).
RT-PCR
Reverse transcription-PCR was performed as described
previously (Osada et al., 2003). The primers and PCR cycles
used were as follows: histone H4, forward, 5V-CGGGA-
TAACATTCAGGGTATCACT-3V and reverse, 5V-ATC-
CATGGCGGTAACTGTCTTCCT-3V, 22 cycles; and
XHR1 (3V untranslated region [UTR]), forward 5V-
CTTTGAAGGGTGCAAGA-3V and reverse 5V-GAGGGA-
CATGGAAGTCT-3V, 30 cycles. The XHR1-3VUTR primer
set was used to detect the mRNA of endogenous XHR1 but
not that of injected XHR1 constructs.Results
Identification of candidate target genes of XHR1 using a
differential cDNA macroarray
To identify downstream target genes of the transcrip-
tional repressor protein XHR1 by differential cDNA
Fig. 2. Results of macroarray. Representative data for 9600 clones from a
stage 15 library are shown. Intensity of each clone was plotted for DEX+
versus uninjected (A), and DEX+ versus DEX (B). Most dots aligned
well along or in parallel with the y = x line, indicating that large numbers of
clones exhibit no differential expression.
H. Takada et al. / Developmental Biology 283 (2005) 253–267 257macroarray screening, a dominant-negative transcriptional
activator of XHR1 was used to upregulate XHR1 target
genes that are otherwise repressed by endogenous XHR1.
This was required to avoid the effects of XHR1-VP16 on
the mesoderm, because we have observed in previous
experiments that XHR1-VP16 can inhibit gastrulation
when ectopically expressed in the mesoderm. For this
purpose, and in order to minimize experimental variation,
we generated a hormone-inducible XHR1-VP16, desig-
nated XHR1-VP16-GR, in which XHR1-VP16 is fused to
GR (Kolm and Sive, 1995). We first tested whether
XHR1-VP16-GR acts as a dominant-negative construct in
the presence of DEX, as has been shown for XHR1-VP16
(Shinga et al., 2001). XHR1-VP16-GR mRNA, together
with nh-gal mRNA as a tracer, was injected into the dorsal
left blastomere of four-cell-stage Xenopus embryos. Early
neurula embryos with nh-gal staining in the pre-MHB
region were selected for the analysis of the expression
levels of the MHB genes Pax2 and En2 by WISH,
comparing the injected side (left) and the non-injected side
(right). As shown in Fig. 1A, there was no detectable
difference in the expression levels of Pax2 (Fig. 1A, left)
or En2 (not shown) between the left and right sides
without DEX. When injected embryos were treated with
DEX at the gastrula stage (stages 10.5–11), a remarkable
reduction in Pax2 (Fig. 1A, right) and En2 (data not
shown) expression was observed on the injected side.
These data suggest that XHR1-VP16-GR functions as a
dominant-negative XHR1 to reduce MHB marker gene
expression in a DEX-dependent manner, consistent with
our previous observation that XHR1-VP16 abolishes MHB
marker expression. To minimize the undesired effects of
activated XHR1-VP16-GR on earlier development, such as
gastrulation arrest, which was observed with high fre-
quency when DEX was added at the 32-cell stage (stage
6), and to ensure that the effect of XHR1 on the reduction
of Pax2 expression was sufficient in DEX-treated
embryos, we added DEX at the early- to mid-gastrula
stages (stage 10.5–11) (Fig. 1B).
We assumed that some XHR1 target genes might be
expressed in a relatively small area around the pre-MHB
region, or that some other target genes might also be
expressed abundantly in another region separate from the
pre-MHB region. To maximize the difference in mRNA
levels of target genes in embryos expressing XHR1-VP16-
GR with DEX (referred to as DEX+) compared with DEX-
untreated (referred to as DEX) or uninjected control
embryos, we dissected out a small piece of anterior
neuroectodermal tissue containing the pre-MHB region
(Fig. 1C). To select embryos that expressed XHR1-VP16-
GR in the pre-MHB region, and also allow us to dissect out
only the region that expressed XHR1-VP16-GR, GFP
mRNA was coinjected as a tracer. As shown in Figs. 1D
and 1E, WISH and semi-quantitative RT-PCR verified the
dissection of the pre-MHB region: the pre-MHB pieces
predominantly contained XHR1-expressing regions (Fig.1D) and had more concentrated endogenous XHR1 mRNA
than the carcass (Fig. 1E).
To identify genes that were enriched in the DEX+
samples compared with the DEX and uninjected sam-
ples, we screened Xenopus cDNA macroarray membranes
containing 48,000 clones by hybridization with labeled
cDNA probes prepared from total RNA extracted from the
dissected DEX+, DEX, or uninjected samples. The
intensity of each clone with ‘‘DEX+’’, ‘‘DEX’’, or
‘‘uninjected’’ probe was measured, and plotted as DEX+
versus DEX for a single set of experiments, and as
DEX+ versus uninjected for two individual sets of
experiments (Fig. 2). These data were processed separately,
and those clones that displayed the same trends in the
DEX+/DEX data sets and DEX+/uninjected data sets
were selected for further analysis (Table 1). In screening
for upregulated genes, clones were selected that showed >
20% upregulation in DEX+ versus DEX data and > 40%
upregulation in DEX+ versus uninjected data, and had an
intensity of more than 3.0 arbitrary units in DEX+.
Because most clones in our macroarray have ‘‘sibling’’
clones that belong to the same contig based on their 5V-
and 3V-EST sequences, we also examined the reproduci-
bility of the results among those sibling clones (Table 1).
In screening for downregulated genes, clones with a
DEX+/DEX ratio lower than 1, a DEX+/uninjected ratio
lower than 0.6, and an intensity higher than 7.0 arbitrary
units in uninjected samples were selected, and the
reproducibility of the results for clones in each contig
was examined (Table 2).
Based on our criteria, we chose the following 14 clones
as upregulated genes to be analyzed further (described in
terms of homologous genes): (1) human elongation of very
long fatty acids-like 1 (hElovl1); (2) E(spl)-related (ESR) 7
(ESR7, the same as ESR3); (3) inhibitor of differentiation
2 (Id2); (4) ESR1; (5) ESR2; (6) midkine; (7) X. laevis
cleavage 2 (XLCL2); (8) ESR9; (9) no homolog; (10)
ESR1; (11) no homolog; (12) Xhox7.1/Msx1; (13) X. laevis
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and (14) no homolog (Table 1). Notably, five of the 14
clones are members of the ESR/Hes family to which XHR1
belongs. We also chose four clones to represent the
downregulated genes (described in terms of homologous
genes): (15) no homolog; (16) Zic3; (17) repulsive
guidance molecule A (RGM); and (18) Zic1.
Expression analysis of candidate XHR1 target genes in
whole embryos
To assess whether the selected genes are actually
upregulated in the region where XHR1-VP16-GR is
expressed in a DEX-dependent manner, and to examine
the expression patterns of these genes, we performed
WISH analysis with embryos that had been injected
with XHR1-VP16-GR and nh-gal mRNAs on the left
side, then treated with DEX (hereafter referred to as
XHR1-VP16-GR/+DEX). Twelve of fourteen ‘‘upregu-
lated’’ clones showed enhanced expression in nh-gal-
positive regions in early neurula embryos, including the
pre-MHB region (Table 1). All of the four ‘‘down-
regulated’’ clones showed a reduction in their expression
in nh-gal-positive regions induced by XHR1-VP16-GR/
+DEX (Table 2). These data demonstrate the successful
detection of mRNA levels in injected embryos using our
macroarray procedures with dissected pre-MHB tissue
fragments.
We also examined the normal expression patterns of
those clones by observing the right sides of embryos,
where mRNA had not been injected. Because XHR1 is
thought to act as a transcriptional repressor, the expres-
sion of its target genes should be repressed in the MHB
region where XHR1 is expressed, and normal gene
expression levels in the neural plate should be reasonably
high. Therefore, we omitted clones 1, 3, 6, 12, and 13
based on their expression patterns, and clone 5 (ESR2)
because of its very low level of expression (data not
shown). For further analysis, we chose clones 2, 4, 7, 8,
and 10, and determined their entire cDNA sequences to
identify the following genes: clone 2, the same as ESR3/
7 and a possible pseudoallele of ESR3/7, referred to
ESR3/7b (accession no. AB211545; see Table 1); clone 4, a
possible pseudoallele of ESR1, referred to as ESR1b
(accession no. AB211546); clone 7, the same as XLCL2;
clone 8, a possible pseudoallele of ESR9, referred to as
ESR9b (accession no. AB211547); and clone 10, the same
as ESR1.
As reported previously, ESR1 is expressed in an arc
shape in the anterior neural plate, and also in three
longitudinal stripes on each side of the posterior neural
plate, with a gap between the anterior and posterior regions
of expression (Schneider et al., 2001). ESR1b, ESR3/7b,
and ESR9b showed almost the same expression pattern as
ESR1 (Deblandre et al., 1999) (see Figs. 3 and 4; ESR3/
7b, data not shown). We assume that ESR1b, ESR3/7b,
Table 2
Summary of the selected clones downregulated by XHR1-VP16-GR
Clone
no.
Homologous gene Accession
no.
Identity
based on ESTs
E-value No. of downregulated clones Total no.
of sibling clones
Results
of WISHUninj. vs. DEX+ DEX vs. DEX+
15 None – No hit N/A 9 8 11 +
16 Zic3 AB005292 91% 0.0 3 2 3 +
17 Repulsive guidance
molecule A
BC045008 81% 3e82 3 2 3 +
18 Zic1 AF022927 81% 0.0 4 4 6 +
In the column of Results of WISH, + indicates that downregulation was assessed in the DEX-treated embryos.
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ESR9, respectively, and, therefore, we used the ESR1b,
ESR3/7b, and ESR9b clones in the following studies,
represented as ESR1, ESR3, and ESR9 hereafter just for
simplicity.
XLCL2 was first identified as a gene that is expressed in
the cleavage stages (Paris and Philippe, 1990), but its
developmental expression and function have not yet been
reported in Xenopus. Interestingly, we found that XLCL2 is
specifically expressed in the anterior neural plate (Fig. 3).
To assess whether these candidate target genes are expressed
in the region in which XHR1 is expressed, we used two-
color WISH with either the ESR1 or XLCL2 probe together
with the XHR1 probe. As shown in Fig. 3, XHR1 expression
(turquoise) just fits into the gap between the arc-shaped and
striped regions of ESR1 expression (purple), and appears to
border the posterior edge of the region of XLCL2 expression
(purple) at the early neurula stage. These complementary
expression patterns supports the idea that these ESR genes
and XLCL2 are target genes repressed by XHR1, and are
therefore not expressed in the region where XHR1 is
expressed.
Direct activation by XHR1-VP16-GR
We next tested whether ESR1, ESR3, ESR9, and XLCL2
are direct target genes of XHR1. If a gene is directly
activated by XHR1-VP16-GR, this activation does not
require protein synthesis. This indicates that the basicFig. 3. The results of two-color WISH for ESR1 (left column, purple) or
XLCL2 (right column, purple) and XHR1 (turquoise). Arrows indicate
XHR1 expression in the pre-MHB region.DNA-binding domain of XHR1 can bind to the enhancer
of the gene, regulating its expression. In this experiment, we
also tested whether or not Xngnr1, Xdelta1, and XHR1 are
directly activated by XHR1-VP16-GR, because the pre-
MHB region is known to be a neuron-free zone (Geling et
al., 2003; Hirata et al., 2001), and because XHR1 might be
autoregulated. We treated injected embryos at the gastrula
stage (stage 10.5–11) with a protein synthesis inhibitor,
cycloheximide (CHX), 30 min before DEX treatment
(referred to as XHR1-VP16-GR/+CHX/+DEX). This CHX
treatment condition has been shown to inhibit protein
synthesis-dependent indirect induction by a hormone-
inducible transcription factor or activin treatment (Yama-
moto et al., 2003). Curiously, the treatment of embryos with
CHX by itself completely abolished ESR1 expression,
whereas it rather upregulated Xngnr1 in the interstripe
regions and XHR1 (Figs. 4Aa,e,f, third panels from the left),
and distorted the ESR9, XLCL2, and Xdelta1 expression
pattern (Figs. 4Ab,c,d, third panels). We speculate that some
positive or negative regulators may turn over rapidly and
therefore disappear quickly in the presence of CHX.
Although CHX treatment itself disturbs expression patterns
of these genes, DEX treatment in the presence of CHX
resulted in an extensive increase in the expression of ESR1,
ESR9, XLCL2, Xdelta1, Xngnr1, and XHR1 (Fig. 4A, fourth
panels) as well as ESR3 (data not shown) in the nh-gal-
positive area, indicating that XHR1-VP16-GR directly
activated these genes. Consistent with this observation, in
the pre-MHB region of wild-type embryos, Xdelta1 is
expressed at lower levels and Xngnr1 expression is not
detected (Chitnis et al., 1995; Ma et al., 1996) (indicated by
arrows in Figs. 4Ad,e, first panel). These data suggest that
ESR1, ESR3, ESR9, XLCL2, Xngnr1, and Xdelta1 are direct
target genes of XHR1, and that XHR1 is autoregulated.
Activation of Xngnr1 by XHR1-VP16-GR/+DEX raised
the question of whether or not repression of MHB genes is
mediated by premature neurogenesis in the MHB region, as
has been suggested in mice and zebrafish (Geling et al.,
2003; Hirata et al., 2001). We tested this possibility using
the proneural gene Xash3 (Zimmerman et al., 1993), the
motor neuron marker Xlim3 (Taira et al., 1993), and the
neuronal differentiation marker b2-tubulin (Good et al.,
1989). As shown in Fig. 4B, none of them were strongly
upregulated by XHR1-VP16-GR/+DEX, though Xlim3 was
slightly activated (Fig. 4Ba) similar to Xngnr1 (Fig. 4Ae),
H. Takada et al. / Developmental Biology 283 (2005) 253–267260
H. Takada et al. / Developmental Biology 283 (2005) 253–267 261and Xash3 was rather downregulated (Fig. 4Bb), suggesting
that reduction of MHB gene expression by XHR1-VP16-
GR/+DEX is not only due to premature neurogenesis in the
pre-MHB region.
XHR1 is necessary and sufficient for the repression of ESR
genes in the MHB region
To assess whether the wild-type XHR1 is sufficient for
the repression of the ESR genes, we performed misexpres-
sion experiments in regions where the ESR genes are
normally expressed. We injected wild-type XHR1 mRNA
together with nh-gal mRNA into the dorsal left blastomere
at the four-cell stage and examined the expression of ESR1,
ESR3, and ESR9 by WISH. The endogenous expression of
ESR1 (Fig. 5Aa), ESR3, or ESR9 (data not shown) was
abolished in the nh-gal-positive region, indicating that
XHR1 can act as a repressor of these ESR genes. We also
observed that the misexpression of XHR1 greatly reduced
the expression of XLCL2 (Fig. 5Ab) as well as that of
Xngnr1 and Xdelta1 (data not shown).
To determine whether XHR1 is required for the
repression of the candidate target genes in the pre-MHB,
we performed loss-of-function analysis with antisense
morpholino oligos directed against XHR1 mRNA (XHR1-
MOs). Embryos were injected with XHR1-MOs together
with nh-gal mRNA in the dorsal left blastomere and were
subjected to WISH to examine expression patterns. As
shown in Figs. 5Ba,aV, injection of XHR1-MOs upregulated
ESR1 expression in the MHB region at the neurula stage,
notably filling the gap between the anterior arc-shaped
region of expression and the medial stripe of posterior
expression, and extending the intermediate stripe anteriorly.
We next tested the specificity of XHR1-MOs. As shown
in Fig. 5Bb, the injection of XHR1-5mmMO did not lead to
the upregulation of ESR1 in the pre-MHB region, suggest-
ing that XHR1-MOs act specifically when the sequence of
the MO matches the target sequence perfectly. To perform
rescue experiments, embryos were injected with XHR1-
MOs into the dorsal left blastomere at the four-cell stage,
incubated until the eight-cell stage, then injected with
different amounts of XHR1 mRNA that did not contain
the target sequences of XHR1-MOs together with nh-gal
mRNA into the dorsal left blastomere at almost the same
point corresponding to the site of injection for MOs.
Injection of XHR1 mRNA, but not of globin mRNA,
reversed the effects XHR1-MOs on ESR1 expression (Figs.
5Bc,d). The percentage of embryos showing ectopic ESR1Fig. 4. The effects of XHR1-VP16-GR on the expression of possible target genes an
are activated by XHR1-VP16-GR in the presence of CHX. Embryos were injected
mRNA (100 pg), and treated with or without CHX for 30 min before the addition (
of ESR1 (a), ESR9 (b), XLCL2 (c), Xdelta1 (d), Xngnr1 (e), and XHR1 (f) were
expression of neuronal markers. The expression of Xlim3 (a), Xash3 (b), and b
proportion of the presented phenotype per total number: numbers in black, norm
expression; numbers in blue, downregulation. Black arrows in Ad,e, pre-MHB
expression.expression in the pre-MHB region was 36% (8/22; i.e., 1
minus 14/22) for XHR1-MOs + XHR1 mRNA, which is
lower than the 81% (30/37) for XHR1-MOs and the 88%
(14/16) for XHR1-MOs + globin mRNA, indicating that
XHR1-MOs elicited the upregulation of ESR1 in the pre-
MHB by specifically inhibiting the endogenous XHR1
function. Similar to ESR1, ESR9 was upregulated in the pre-
MHB region by XHR1-MOs (Figs. 5Be,eV), while ESR3
was weakly upregulated because its normal expression level
is very low (data not shown). These data suggest that XHR1
is necessary and sufficient to repress the expression of the
ESR genes in the pre-MHB region.
XHR1-MOs affect the expression of Xdelta1 and Pax2
XHR1-MOs distorted the Xdelta1 expression to narrow
the gap at the MHB (Fig. 5Bg), but failed to upregulate the
expression of XLCL2 or Xngnr1 in the pre-MHB region in
contrast to the ESR genes (see Discussion). We further
examined the effects of XHR1-MOs on the expression of the
MHB gene Pax2, which is thought to be a positive regulator
of pre-MHB development and an indirect target of XHR1
(Shinga et al., 2001). The injection of XHR1-MOs resulted in
the downregulation of Pax2 expression in the early neurula,
suggesting that XHR1 is required for the proper early
establishment of the pre-MHB. The reduction in Pax2
expression, however, was not complete in the majority of
the injected embryos (Fig. 5Bi). This partial reduction in
Pax2 expression by XHR1-MOs showed tendency to be
rescued by injection of XHR1 mRNA but not by injection of
globin mRNA (Figs. 5Bk,l). The relatively weak effect of
loss-of-function of XHR1 induced by XHR1-MOs on Pax2
expression is consistent with the previous observation that
injection of the derepression-type dominant-negative con-
structs of XHR1, mb-XHR1 (in which the basic DNA-
binding region was point-mutated) and XHR1-DWRPW (in
which the C-terminalWRPWrepression domain was deleted)
downregulated Pax2, but not as strongly as the activator-type
dominant-negative XHR1, XHR1-VP16 (Shinga et al.,
2001). As in the case of mb-XHR1 and XHR1-DWRPW,
the downregulation of Pax2 and ESR1 by XHR1-MOs was
no longer detected at the late neurula or tailbud stage (data not
shown; see Discussion).
Misexpression of ESR1 disrupts MHB formation
The results described above suggest that XHR1 directly
represses ESR1, at least in the medial and intermediate partsd neuronal markers. (A) ESR1, ESR9, XLCL2, Xdelta1, Xngnr1, and XHR1
into the dorsal left blastomere at the four-cell stage with XHR1-VP16-GR
or not) of DEX at the gastrula stage (stage 11), as indicated. The expression
analyzed at stage13 by WISH. (B) The effects of XHR1-VP16-GR on the
2-tubulin (c) was analyzed at stage 13 by WISH. Fractions indicate the
al expression; numbers in red, upregulation; numbers in green, disrupted
region; red arrow in Ba, ectopic expression; black arrow in Bb, reduced
Fig. 5. The effects of gain-of-function or loss-of-function of XHR1 on expression gene. (A) Misexpression of XHR1 represses ESR1 and XLCL2 expression.
XHR1 mRNA (12.5–25 pg) was injected into the dorsal left blastomere at the four-cell stage. ESR1 (a) and XLCL2 (b) expression was examined by WISH at
stage 13–14. Each stripe in which primary neurons arise is numbered in the expression of ESR1. 1, Medial stripe; 2, intermediate stripe; 3, lateral stripe.
Arrows, reduced expression. (B) Effects of XHR1-MOs on the expression of ESR1 (a–d), ESR9 (e, f), Xdelta1 (g, h), and Pax2 (i – l). XHR1-MOs (a, e, g, i) or
XHR1-5mmMO (b, f, h, j) was injected at the four-cell stage, and globin (c, k; negative control) or XHR1 (d, l) mRNAwas injected with nh-gal mRNA at the
eight-cell stage. (aV, eV) Magnification of the same embryo as shown in panels a and e. Black arrows, reduced expression; red arrows, ectopic expression.
Fractions in black, normal expression; in blue, downregulation; in red, upregulation. Injected doses: MOs, 6 or 3 (i, j) ng; globin or XHR1 mRNA, 3–10 (d), or
0.3–1 (l) pg.
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of ESR1 by XHR1 is required for the proper development of
the MHB, we misexpressed ESR1 in the pre-MHB region
and examined its effects on MHB gene expression. As
shown in Fig. 6, ESR1 as well as ESR3 and ESR9 (data not
shown) strongly reduced Pax2 expression, suggesting that
the repression of ESR1 by XHR1 is necessary for the proper
expression of MHB genes. Furthermore, misexpression of
ESR1 also downregulated XHR1 expression.
Because XLCL2/Lbh has been suggested to function as a
coactivator (Briegel and Joyner, 2001) and its expression is
restricted to the anterior neural plate, this protein might have
some roles in neural patterning, and perhaps disturbs MHBformation. Therefore, we misexpressed XLCL2 in the pre-
MHB region and assayed for MHB gene expression.
However, neither XHR1 nor Pax2 expression was affected
by XLCL2 (data not shown), implying that a transcription
factor(s) functioning with XLCL2, if any, might be absent in
the pre-MHB region.
Notch signaling does not activate XHR1 expression
Many bHLH-WRPW transcriptional repressors, includ-
ing ESR1, ESR3, and perhaps ESR9 are activated by Notch
signaling and play a role in the maintenance of neural stem
cell and progenitor cell fates (Davis and Turner, 2001).
Fig. 6. ESR1 downregulates Pax2 and XHR1 expression. ESR1 mRNAwas
injected at 100–400 pg per blastomere. Pax2 and XHR1 expression was
analyzed at stage 13. Arrows, reduced expression. Fractions in black,
normal expression; in blue, downregulation.
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induction of XHR1 is dependent on the Notch signaling
pathway. To address this question, we analyzed the
expression of XHR1 under conditions in which Notch
signaling is activated by the overexpression of a con-
stitutively active Notch, Notch ICD, or is repressed by a
dominant-negative mutant of Su(H)1, designated
Su(H)1DBM, which does not bind DNA but still associates
with Notch ICD (Wettstein et al., 1997). As shown in Fig.
7, the overexpression of ICD did not lead to the
upregulation of XHR1, but rather to a dramatic reduction
in XHR1 expression without affecting the expression of a
pan-neural gene, SOX2, whereas it upregulated ESR1
expression as reported previously (Wettstein et al., 1997).
When Notch signaling was inhibited by the overexpression
of Su(H)1DBM, ESR1 expression was downregulated as
expected (Wettstein et al., 1997), whereas XHR1 expres-
sion was unaffected (data not shown). These data suggest
that XHR1 is not a direct target of Notch-ICD-Su(H)
signaling.Fig. 7. Notch signaling does not activate XHR1 expression. Notch-ICD
mRNA was injected at 250–1000 pg per blastomere. The expression of
ESR1, XHR1, and Sox2 was analyzed at stage 13. Arrow, reduced
expression. Fractions in white, normal expression; in blue, downregulation;
in red, upregulation.Discussion
In this study, we undertook large-scale screening for
genes regulated by XHR1 in order to decipher the molecular
mechanisms of early neural patterning and pre-MHB
specification. Our data strongly suggest that bHLH-WRPW
transcriptional repressor genes, ESR1, ESR9, and perhaps
ESR3 are direct target genes of XHR1, and that XLCL2,
Xdelta1, Xngnr1, and XHR1 can also be direct targets for
XHR1. As discussed below, we propose that XHR1
demarcates the pre-MHB region from the surrounding
neuroectoderm as a prepattern gene, which was originally
defined in Drosophila notal development as a gene
determining two-dimensional pattern formation in the
epithelium (Calleja et al., 2002).Target genes of XHR1 in the pre-MHB region
The following lines of evidence suggest that ESR1, -3,
and -9 are direct targets of XHR1: (1) XHR1-VP16-GR
upregulated the ESR genes in the presence of DEX even
after treatment with CHX (designated XHR1-VP16-GR/
+CHX/+DEX) (Fig. 4A); (2) overexpression of wild-type
XHR1 led to the downregulation of the ESR genes (Fig.
5A); (3) knockdown experiments using XHR1-MOs
resulted in the ectopic expression of the ESR genes only
in the pre-MHB region, which occurs in the gap between
the medial stripe and arc-shaped regions of ESR
expression (Fig. 5B); and (4) the effect of XHR1-MOs
seemed to be specific because coinjection of XHR1
mRNA rescued, though partially, the XHR1-MOs pheno-
type (Fig. 5B; only assayed for ESR1). Therefore, of the
14 genes that we initially selected as possible target genes
for XHR1, these ESR genes are most likely to be direct
targets of XHR1.
Although there is no clear evidence that XHR1 is
required for the repression of XLCL2, Xngnr1, and Xdelta1
in the pre-MHB region, as assayed by MO injection, we still
think that those genes are also good candidates for direct
targets of XHR1 based on their responsiveness to XHR1-
VP16-GR as XLCL2, Xngnr1, and Xdelta1 were strongly
upregulated by XHR1-VP16-GR/+CHX/+DEX, similar to
ESR1 (Fig. 4A), and on their expression patterns comple-
mentary to that of XHR1 (Fig. 3; see Figs. 4Ad,e). Given
that XLCL2, Xngnr1, and Xdelta1 are direct targets of
XHR1, the question remains: why are XLCL2, Xngnr1, and
Xdelta1 not or less upregulated by microinjection with
H. Takada et al. / Developmental Biology 283 (2005) 253–267264XHR1-MOs, in contrast to ESR1? We conjecture that there
might be other repressors that are redundant for XHR1
function in repressing XLCL2, Xngnr1, and Xdelta1 in the
pre-MHB region, or that there might be differences in the
sensitivity of ESR1 and those three genes to the level of
XHR1 protein. For example, XLCL2, Xngnr1, and Xdelta1
may be repressed by lesser amounts of XHR1 than is ESR1
and ESR9, because the translation of XHR1 mRNA is
probably not completely repressed by MOs.
In the CHX experiments (Fig. 4A), we have noticed
that Xngnr1 and Xdelta1 are not strongly upregulated by
XHR1-VP16-GR when treated with DEX alone (XHR1-
VP16-GR/+DEX). Because the E(spl) family members
downstream from Notch signaling are thought to repress
neuronal differentiation (Cau et al., 2000; Schneider et al.,
2001; Takke et al., 1999), one possible explanation for
this result is that XHR1-VP16-GR/+DEX strongly upre-
gulates E(spl)-related genes, the products of which in turn
inhibit the upregulation of Xngnr1 and Xdelta1 by XHR1-
VP16-GR/+DEX. Those repressors are likely to be ESR
genes which are activated by XHR1-VP16-GR/+DEX
(Table 1).Fig. 8. Models of the pre-MHB formation by XHR1. (A) Possible gene interactions
Xngnr1, Xdelta1, XLCL2, and yet identified genes (?). XHR1 is likely to repre
prepatterns by Notch and Xdelta1 (a; expression patterns are simplified) and XH
Discussion for more detail.In contrast to ESR1, ectopic expression of XLCL2 (the
Xenopus ortholog of mouse Lbh; Briegel and Joyner, 2001)
could not repress MHB gene expression; however, we found
that anterior neural marker Otx2 was ectopically expressed
in XLCL2 injected area (data not shown), indicating that
XLCL2 play some roles in AP patterning in neural plate. It
may be possible that XHR1 defines the posterior edge of the
midbrain region by repressing XLCL2 expression.
Interactions between XHR1 and Notch
In the neural plate of the Xenopus embryo, Notch is
expressed in a wide area (Chitnis et al., 1995), including the
pre-MHB region (Shinga et al., unpublished). One of the
Notch ligand genes, Xdelta1, is expressed in a more discrete
pattern, with higher levels of expression along the midline
and in two other regions on the lateral surfaces, and lower
expression in the pre-MHB region (Figs. 4Ad and 5Bh).
These observations indicate that the pre-MHB is not
completely devoid of Notch and Xdelta1 expression; in
other words, the pre-MHB could be competent for ESR1
activation (Fig. 8Ba). This point of view explains the. XHR1 demarcates the pre-MHB region by repressing ESR1, ESR3, ESR9,
ss own transcription. (B) Prepatterns in the neural plate. Combination of
R1 (b) specifies expression patterns of ESR genes (c) and Pax2 (d). See
H. Takada et al. / Developmental Biology 283 (2005) 253–267 265ectopic expression of ESR1 in the pre-MHB region as
stripes when XHR1 is knocked down.
Our data have suggested possible regulatory interactions
which are summarized in Fig. 8A. In this model, XHR1
downregulates ESR1, Xngnr1, and Xdelta1 in the pre-MHB
region to inhibit both upstream and downstream from Notch
signaling. In addition, our data have suggested that XHR1 is
not activated by Notch signaling (Fig. 7), and that ESR1 as
well as XHR1 itself can inhibit XHR1 expression (Fig. 6;
data not shown). This mutual inhibition possibly creates the
boundary between the XHR1-expressing pre-MHB region
and the adjacent proneural region in which Delta-Notch
signaling is operated. Negative autoregulation of XHR1
may be to maintain a proper level of XHR1 expression as
has been suggested in a model system (Becskei and Serrano,
2000).
Mechanisms of pre-MHB specification and regionalization
involving XHR1 function
In the chick, mouse, and zebrafish, a repressive
interaction between Otx2 and Gbx2 demarcates the MHB
region, and is required for the maintenance but not for the
induction of MHB gene expression (Broccoli et al., 1999;
Joyner et al., 2000; Katahira et al., 2000; Li and Joyner,
2001; Millet et al., 1999; Simeone, 2000). We have
previously shown that XHR1 is expressed in the pre-MHB
region before the Otx2 –Gbx2 border is created. Moreover,
the boundary between Otx2 and Gbx2 is first detected on the
lateral side of the neural plate at the late gastrula stage (stage
12) (Glavic et al., 2002), where Pax2 expression is first
detected, and then converges to the midline. In contrast, the
expression of XHR1 starts in the center of the dorsal
neuroectoderm at the early gastrula stage and its expression
in the midline gradually vanishes (Shinga et al., 2001).
These observations suggest the existence of at least two
separate pathways for the development of the pre-MHB.
This is consistent with the existence of multiple genetic
cascades for MHB formation, as has been suggested for
zebrafish (Tallafuss et al., 2001).
We have shown that Pax2 is downregulated by XHR1-
VP16-GR/+DEX (Fig. 1A), but this is probably not merely
due to premature neuronal differentiation as assayed by
Xngnr1, Xlim3, Xash3, and b2-tubulin expression (Figs.
4Ae, 4B). Consistent with the results of XHR1-VP16-GR
experiments, loss-of-function by XHR1-MOs does not
upregulate Xngnr1 and b2-tubulin, but downregulates
Pax2 in the pre-MHB region (Fig. 5). Because loss-of-
function of mouse Hes1 and Hes3 or zebrafish her5 disrupts
MHB formation through premature neurogenesis (Geling et
al., 2003; Hirata et al., 2001), it is also possible that bHLH-
WRPW repressors other than XHR1 inhibit neurogenesis in
the pre-MHB region.
The reduction of Pax2 expression by XHR1-MOs is
thought to be mediated, at least in part, by the ectopic
expression of ESR genes, because ESR genes misexpressioninhibits Pax2 expression (Fig. 6). However, the reduction in
Pax2 expression in the more lateral regions of the pre-MHB,
where the ESR genes are not ectopically expressed, could be
mediated by other factors yet to be identified. Therefore,
XHR1 could act as an upstream component of Pax2
expression (Fig. 8A). Pax2 is thought to act as a positive
regulator that maintains the expression of its own gene, as
well as that of other MHB genes (Picker et al., 2002; Wurst
and Bally-Cuif, 2001), which may include XHR1.
In zebrafish, loss-of-function of a homolog of XHR1,
her5, by antisense MOs upregulates neurogenin 1 and the
Cdk inhibitor p27xic1 in the pre-MHB region, but does not
affect the expression of the MHB gene pax2.1 (Geling et al.,
2003). It has also been shown that Her5 directly binds to
CATGTG (Class B site; Fisher and Caudy, 1998) in a
regulatory element of the neurogenin 1 gene to repress its
expression (Geling et al., 2004). To investigate whether
her5 is a functional equivalent of XHR1 in the MHB
formation, it will be needed to examine whether XHR1
directly inhibits p27Xic1 and whether her5 directly inhibits
the orthologs of ESR1, ESR3, ESR9, and Xdelta1.
Function of XHR1 as a prepattern gene
The neural plate becomes regionalized along the
anteroposterior and mediolateral axes during development.
This two-dimensional patterning provides us a model
system to study prepattern genes, as has been shown in
Drosophila notal development, in which many transcrip-
tion factors, such as hairy, iroquois, and pannier, are
involved. These genes define not only the region where
neurons arise but also notal morphology such as muscle
attachment sites and pigmentation patterning (Calleja et al.,
2002). In vertebrates, it has been shown that Xrx1, Zic2,
Xiro3 (in Xenopus), her5, her3 (in zebrafish), and perhaps
Hes3 (in mouse) function as prepattern genes for neuro-
genesis in the neural plate to maintain undifferentiated
states by inhibiting the proneural gene neurogenin, and the
Notch ligand gene delta, and to promoter cell proliferation
by inhibiting the CDK inhibitor p27Xic1 (Bally-Cuif and
Hammerschmidt, 2003; Brewster et al., 1998; Hans et al.,
2004; Hirata et al., 2001). Other than neurogenesis, Tcf4
and Irx2 have been shown to function as prepattern genes
for muscle patterning in the limb bud and cerebellum
development in the neural plate, respectively (Kardon et
al., 2003; Matsumoto et al., 2004). These prepattern genes
start to be expressed before the morphogenesis starts, and
combinations of gene expression define subregions called
prepatterns.
According to our data, we propose that XHR1 functions
as a prepattern gene for the pre-MHB region as follows.
First, XHR1 starts to be expressed before the expression of
ESR1, ESR9, and MHB genes start (Shinga et al., 2001).
Second, our data with XHR1-MOs revealed that the pre-
MHB region has a potential for striped expression of ESR1
and ESR9 (Figs. 5Ba,e). This potentiality is probably
H. Takada et al. / Developmental Biology 283 (2005) 253–267266conferred by the expression of Notch and Xdelta1 as
continuous stripes as shown in Fig. 8Ba. This prepattern
overlaps with that of XHR1 expression as shown in Fig.
8Bb to bring about the expression pattern of ESR1 and
ESR9 (Fig. 8Bc). Concomitantly, the MHB gene Pax2 is
expressed in the pre-MHB region where XHR1 defines by
inhibiting ESR genes and so on (Fig. 8Bd). Thus, XHR1
appears to act as a prepattern gene to execute the initial
step of pre-MHB formation as one of the early prepatterns
in the vertebrate neuroectoderm, because XHR1 expression
starts at the beginning of neural induction and patterning at
the early gastrula stage.Acknowledgments
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